Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingjiang Xu

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Gut|February 12, 2014
Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?Bin Gao, Mingjiang Xu
Expert Opinion on Therapeutic Targets|December 23, 2025
Paraspeckle component 1 in acute myeloid leukemia: prospects for therapeutic targetingMingjiang Xu, Jianlong Wang
Hepatology (Baltimore, Md.)|April 14, 2015
ReplyDechun Feng, Mingjiang Xu, Bin Gao
Hepatology (Baltimore, Md.)|June 9, 2015
ReplyMingjiang Xu, Dechun Feng, Bin Gao
Blood|September 5, 2021
Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesisYi Qiu, Mingjiang Xu, Suming Huang
Blood|June 8, 2006
Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia veraTakefumi Ishii, Edward Bruno, Ronald Hoffman, et al.
Hepatology International|July 24, 2015
New drug targets for alcoholic liver diseaseMingjiang Xu, Binxia Chang, Stephanie Mathews, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 5, 2014
Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challengesStephanie Mathews, Mingjiang Xu, Hua Wang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 27, 2009
Sensitive detection of MPLW515L/K mutations by amplification refractory mutation system (ARMS)-PCRJian Zhuge, Wenyong Zhang, Wei Zhang, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 13, 2012
Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese miceHongliang Li, Mingjiang Xu, Jiyeon Lee, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Gut|February 12, 2014
Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?Bin Gao, Mingjiang Xu
Expert Opinion on Therapeutic Targets|December 23, 2025
Paraspeckle component 1 in acute myeloid leukemia: prospects for therapeutic targetingMingjiang Xu, Jianlong Wang
Hepatology (Baltimore, Md.)|April 14, 2015
ReplyDechun Feng, Mingjiang Xu, Bin Gao
Hepatology (Baltimore, Md.)|June 9, 2015
ReplyMingjiang Xu, Dechun Feng, Bin Gao
Blood|September 5, 2021
Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesisYi Qiu, Mingjiang Xu, Suming Huang
Blood|June 8, 2006
Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia veraTakefumi Ishii, Edward Bruno, Ronald Hoffman, et al.
Hepatology International|July 24, 2015
New drug targets for alcoholic liver diseaseMingjiang Xu, Binxia Chang, Stephanie Mathews, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 5, 2014
Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challengesStephanie Mathews, Mingjiang Xu, Hua Wang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 27, 2009
Sensitive detection of MPLW515L/K mutations by amplification refractory mutation system (ARMS)-PCRJian Zhuge, Wenyong Zhang, Wei Zhang, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 13, 2012
Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese miceHongliang Li, Mingjiang Xu, Jiyeon Lee, et al.
Pageof 14